Trial Profile
phaseII/ III study at GSK1358820 for spasmodic dysphonia patients
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Dysphonia
- Focus Therapeutic Use
- Acronyms BOISS Study
- 02 Jun 2016 New trial record